--- /home/parlparse/parldata/cmpages/lordspages/daylord2007-10-22a.html	2007-10-23 08:07:58.000000000 +0100
+++ /home/parlparse/parldata/tmp/patchtmp-daylord2007-10-22a-JoJtpi.html	2007-10-23 09:00:45.000000000 +0100
@@ -4254,11 +4254,11 @@
 </ul>
 
 <p><a name="wa_st_30"></a>
-<a name="07102225000192"></a><b><a name="71022w0003.htm_spnew4"></a><a name="07102225000577"></a>Lord Darzi of Denham:</b> Clinical advice is provided to general practitioners and other physicians by the Health Protection Agency (HPA) and this advice is published on the HPA website, available at www.hpa.org.uk. The advice includes guidance for diagnosing Lyme disease together with guidelines for the treatment of Lyme disease. The treatment guidelines published by the Infectious Diseases Society of America in 2006 <sup>[2]</sup> are included within the HPA's advice, together with published guidance for the diagnosis and treatment of neuroborreliosis. <sup>[3,4]</sup> The report of the investigation <sup>[1]</sup> carried out by the Department of Health's inspector of microbiology into the use of unorthodox and unvalidated laboratory tests used to make a diagnosis of chronic Lyme borreliosis disease is also available on the HPA's website.</p>
+<a name="07102225000192"></a><b><a name="71022w0003.htm_spnew4"></a><a name="07102225000577"></a>Lord Darzi of Denham:</b> Clinical advice is provided to general practitioners and other physicians by the Health Protection Agency (HPA) and this advice is published on the HPA website, available at www.hpa.org.uk. The advice includes guidance for diagnosing Lyme disease together with guidelines for the treatment of Lyme disease. The treatment guidelines published by the Infectious Diseases Society of America in 2006 <sup>2</sup> are included within the HPA's advice, together with published guidance for the diagnosis and treatment of neuroborreliosis. <sup>3,4</sup> The report of the investigation <sup>1</sup> carried out by the Department of Health's inspector of microbiology into the use of unorthodox and unvalidated laboratory tests used to make a diagnosis of chronic Lyme borreliosis disease is also available on the HPA's website.</p>
 
 <a name="71022w0003.htm_para19"></a>
 <p><a name="wa_stpa_83"></a><a name="07102225000193"></a>In addition, the HPA's Lyme disease reference unit routinely provides expert diagnostic testing support and advice to clinicians, and&#151;through its nationwide links to experts in infectious diseases, neurology, rheumatology and other specialities who have a particular interest in Lyme disease&#151;can advise on treatment and patient referral as appropriate.</p>
-<ul><a name="07102234000002"></a>Source:</ul><ul><a name="07102234000003"></a><sup>[1]</sup> Duerden BI. Unorthodox and unvalidated laboratory tests in the diagnosis of Lyme borreliosis and in relation to medically unexplained symptoms. Department of Health, London, United Kingdom 2006. www.dh.gov.uk/assetRoot/04/13/89/17/04138917.pdf.</ul><ul><a name="07102234000004"></a><sup>[2]</sup> The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Wormser GP, Dattwyler RJ, Shapiro ED, et al. Clinical Infectious Diseases 2006; 43: 1089-34. Available at www.journals. uchicago.edu/CID/journal/issues/v43n9/40897/40897.html.</ul><ul><a name="07102234000005"></a><sup>[3]</sup> Halperin JJ, Logigian EL, Finkel MF, Pearl RA. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996 46: 619-627.</ul><ul><a name="07102234000006"></a><sup>[4]</sup> Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. E-published ahead of print on 23 May 2007. Available at www.neurology.org/cgi/rapidpdf/0l.wnl.0000265517.66976.28v1.</ul>
+<ul><a name="07102234000002"></a>Source:</ul><ul><a name="07102234000003"></a><sup>1</sup> Duerden BI. Unorthodox and unvalidated laboratory tests in the diagnosis of Lyme borreliosis and in relation to medically unexplained symptoms. Department of Health, London, United Kingdom 2006. www.dh.gov.uk/assetRoot/04/13/89/17/04138917.pdf.</ul><ul><a name="07102234000004"></a><sup>2</sup> The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Wormser GP, Dattwyler RJ, Shapiro ED, et al. Clinical Infectious Diseases 2006; 43: 1089-34. Available at www.journals. uchicago.edu/CID/journal/issues/v43n9/40897/40897.html.</ul><ul><a name="07102234000005"></a><sup>3</sup> Halperin JJ, Logigian EL, Finkel MF, Pearl RA. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996 46: 619-627.</ul><ul><a name="07102234000006"></a><sup>4</sup> Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. E-published ahead of print on 23 May 2007. Available at www.neurology.org/cgi/rapidpdf/0l.wnl.0000265517.66976.28v1.</ul>
 
 
 
